Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AF
- Chemical substanceL04AF02Baricitinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Netherlands
CBG-MEB · 4 registrations
- Olumiant 1 mg, filmomhulde tablettenFilmomhulde tablet · Eli Lilly Nederland B.V.
- Olumiant 2 mg, filmomhulde tablettenFilmomhulde tablet · Eli Lilly Nederland B.V.
- Olumiant 2 mg/ml suspensie voor oraal gebruikSuspensie voor oraal gebruik · Eli Lilly Nederland B.V.
- Olumiant 4 mg, filmomhulde tablettenFilmomhulde tablet · Eli Lilly Nederland B.V.
United States
FDA · 3 registrations
At a glance
- ATC code
- L04AF02
- Registers
- 9
- Historical lists
- 2
- Registrations
- 22
- With their own page
- 17
- Companies
- 8
All medicines with Baricitinib
Human medicines from every register that match Baricitinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
22 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Baricitinib | United States | 1MG, 2MG | tablet | Not marketed | Aurobindo Pharma LTD |
| Olumiant | United States | 1MG, 2MG, 4MG | tablet | Marketed | MSN |
| Olumiant | European Union | Authorised | Eli Lilly Nederland B.V. | ||
| Olumiant 2 MG Comprimidos Recubiertos con Pelicula | Spain | 2,00 mg | comprimido recubierto con película | Marketed | Eli Lilly Nederland B.V. |
| Olumiant 4 MG Comprimidos Recubiertos con Pelicula | Spain | 4,00 mg | comprimido recubierto con película | Marketed | Eli Lilly Nederland B.V. |
| Olumiant 1 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Eli Lilly Nederland B.V. | |
| Olumiant 2 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Eli Lilly Nederland B.V. | |
| Olumiant 2 mg/ml suspensie voor oraal gebruik | Netherlands | Suspensie voor oraal gebruik | Authorised | Eli Lilly Nederland B.V. | |
| Olumiant 4 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Eli Lilly Nederland B.V. | |
| Olumiant | Canada | 2 MG | Tablet | Marketed | Eli Lilly Canada INC |
| Olumiant | Canada | 4 MG | Tablet | Marketed | Eli Lilly Canada INC |
| Olumiant | Brazil | Authorised | Eli Lilly do Brasil Ltda | ||
| Olumiant Film-Coated Tablet 2MG | Singapore | 2.000mg | tablet, film coated | Authorised | DKSH Singapore Pte. LTD. |
| Olumiant Film-Coated Tablet 4MG | Singapore | 4.000mg | tablet, film coated | Authorised | DKSH Singapore Pte. LTD. |
| olumiant® | Serbia | 4mg | film tableta | Authorised | PredstavniŠTvo Eli Lilly (Suisse) SA, Beograd (Novi Beograd) |
| olumiant® | Serbia | 2mg | film tableta | Authorised | PredstavniŠTvo Eli Lilly (Suisse) SA, Beograd (Novi Beograd) |
| Olumiant | Croatia | Marketed | |||
| OLUMIANT 2 mg Film Coated Tablet | Saudi Arabia | Authorised | Lilly del Caribe, INC. | ||
| OLUMIANT 4 mg Film Coated Tablet | Saudi Arabia | Authorised | Lilly del Caribe, INC. | ||
| Baricitinib | United States | Status unknown | |||
| OLUMIANT 2 mg | Romania | 2 mg | compr. film. | Status unknown | Eli Lilly Nederland B.V. |
| OLUMIANT 4mg | Romania | 4mg | compr. film. | Status unknown | Eli Lilly Nederland BV |